ALZHEIMER'S DISEASE (AD)

This study tested an experimental drug called ABBV-916 in people with early Alzheimer's disease. The goal was to see if it is safe and can slow down the disease. About 106 adults aged 50-90 took part. They received either the drug or a placebo by IV every 4 weeks for 6 months, wi…

This study tested a new blood test that uses a special chip to measure two key markers (amyloid-β and PKC) in red blood cells to help diagnose Alzheimer's disease. Researchers collected blood and urine samples from 150 people—50 with Alzheimer's, 50 with other brain diseases, and…

This study looked at whether a computer program called SCALE PET can help doctors more accurately read brain scans for signs of Alzheimer's disease. Researchers used 190 existing brain scans from people with Alzheimer's or mild memory problems. Four doctors reviewed the scans twi…

This study tested whether a special graphene far-infrared device could improve thinking and memory in 126 older adults with mild cognitive decline or Alzheimer's disease. Participants used the device or a placebo for 4 weeks. The study also looked at whether the therapy helped wi…

This study tested whether a nerve block called stellate ganglion block (SGB), given with standard medication, could improve thinking and memory in people with Alzheimer's disease. Forty participants were randomly assigned to receive either SGB plus standard drugs or standard drug…

This study tested an experimental drug called ABBV-552 in people with mild Alzheimer's disease. The goal was to see if it is safe and can help with memory and thinking problems. About 263 adults aged 50 to 90 took a daily pill or a placebo for 12 weeks. Researchers measured chang…

This study followed over 1,100 older adults with normal memory, mild cognitive impairment, or early Alzheimer's to track changes in thinking, brain scans, and blood markers over time. The goal was to find better ways to measure the disease and help design future treatments. Parti…